The combination of PEG interferon (IFN)-α-2a [Pegasys] plus ribavirin [Copegus] was more effective than IFN-α-2a plus ribavirin in the treatment of hepatitis C virus (HCV) infections in patients coinfected with HIV, according to a study presented at the 11th Conference on Retroviruses and...
PEG IFN-alpha-2a + ribavirin for hepatitis C: less impact on QOLHepatitis-C, treatmentInterferon-alpha-2b, therapeutic usePEG-interferon-alpha-2a, therapeutic useQuality-of-lifeRibavirin, therapeutic use
1. PEG-IFNalpha2a +リバビリン療法施行中にB型慢性肝炎の急性増悪を起こしたB型C型重複感染の1例 [J] . 宮田央, 宮田學, 工藤正俊 肝脏. 2012,第12期 机译:一例B型C多发感染,在PEG-IFNα2a+利巴韦林治疗期间引起慢性乙型肝炎急性加重 2. ぺグィンターフェロン,リバビリン,シメプレビル3...
The study results are so important because they show PegIFN-lambda could provide relief for the 20% of HCV patients who have to undergo dose reduction, or cease treatment, on PegIFN-alpha-2a – a part of the current HCV standard of care.2 The trial shows that PegIFN-lambda provides high...
Patient was advised for PEG-IFNalpha- 2a combination therapy for 24 weeks, to which he responded well after 4 week and showed sustained virologic response after 06 months of completion of therapy. His IL-8 and TNF-alpha levels also came to lower levels after treatment with PEG-IFN-alpha 2a...
PEG IFN-alpha-2a flies ahead in chronic hepatitis CInterferon-alpha-2a, therapeutic usePEG-interferon-alpha-2a, therapeutic useResearch-and-developmentHepatitis-C, treatmentCirrhosis, treatmentInpharma
Retreatment with peginterferon [PEG IFN]-α-2a [Pegasys] plus ribavirin [Copegus, Rebetol] is effective in patients with hepatitis C who have not responded to therapy with PEG IFN-α-2b [Peglntron] plus ribavirin, according to preliminary results from the ongoing REPEAT study presented at the...
Position isomers of the mono pegylated interferon alpha 2a, treatment of diseases and isolation procedures, the present invention relates to a use in the manufacture of a medicament for the treatment of viral diseases.ブルッガー,ドリスフォーザー,シュテファン...
本发明涉及单聚乙二醇化的干扰素α-2a的位置异构体,分离其的方法及其在制备用于治疗疾病,特别是治疗病毒性疾病的药物中的应用. The present invention relates to a mono-PEGylated interferon α-2a positional isomers, methods of their separation and in the preparation for the treatment of diseases, ...
The Invention relates to monopegilado positional isomers of interferon alpha 2a, with a method for their Isolation and their use in the manufacture of medicacmentos for the treatment of diseases, especially for the treatment of Viral Diseases.ALFRED SCHACHERDORIS BRUGGERKARL WEYERSTEFAN FOSER...